Statistics for Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC)
Total visits
| views | |
|---|---|
| Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC) | 45 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Figueiredo - 2020 - Real-world data from the Portuguese.pdf(legacy) | 26 |
| Figueiredo - 2020 - Real-world data from the Portuguese.pdf | 9 |
Top country views
| views | |
|---|---|
| United States | 24 |
| China | 5 |
| Germany | 4 |
| Australia | 3 |
| Portugal | 3 |
| Singapore | 3 |
| Brazil | 1 |
| United Kingdom | 1 |
| Russia | 1 |